ATRX and cancer: As a small minority of ALT-cancer cells exhibit DAXX loss, rather than ATRX loss, we generated CRISPR-Cas9 mediated DAXX knockout clones in the HeLa LT cell line, both in the context of wildtype ATRX and ATRX knockout (Supplementary Figure S5A).